Medtronic Hugo™ robotic-assisted surgery system receives Health Canada licence, further enabling access to robotic-assisted surgery in Canada

Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE: MDT), the world's leading medical technology company, announced it has received a Health Canada licence...

Lunit Raises $61M in Funding Round Led By Major Global Healthcare Investors

- New investors include US life science investors HealthQuest Capital, Casdin Capital, and American Cancer Society BrightEdge, and Asia-based global healthcare investors Tybourne Capital Management...

Cardiologs’ AI receives FDA clearance for paediatric use

Cardiologs announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to use its AI-powered cardiac diagnostics platform for...

Charco Neurotech announces $10m investment round and new partnership

Charco Neurotech, a medical technology company that develops solutions for people with Parkinson’s, has announced its $10m seed investment round, co-led by technology investors Amadeus...

Activ Surgical augments VC funding with $45M for AR-based software

Augmented reality has sent people dashing into traffic to catch Pokémon, helped them virtually map out home makeovers and guided them through winding city...

Topcon Healthcare to Partner with RetInSight

Market Leader in OCT & Data Management Joins Forces with AI Expert to Provide Improved Clinical Care Topcon Healthcare of Oakland, NJ, a leading provider...

NuVasive receives CE Mark for Pulse platform and begins global clinical evaluations

NuVasive has revealed that its Pulse platform received CE Mark approval for its latest design update and clinical evaluations are now underway in multiple...

Vietnamese health tech firm develops AI model for TB diagnosis, screening

VinBrain, an AI healthcare software developer in Vietnam, recently came up with an AI model for the diagnosis and screening of tuberculosis. The Vingroup-backed company...

DarioHealth touts research on digital therapeutics for diabetes patients

DarioHealth (NSDQ:DRIO) announced today that recently published research supports its digital therapeutic platform for type 2 diabetes. New York-based DarioHealth published a new study through a...

Latest articles